Bradykinin Potentiator C, Angiotensin I Converting Enzyme Inhibitor is a venom-derived peptide known for interacting with metallopeptidase pathways. Its sequence architecture permits examination of enzyme-binding determinants and substrate protection. Researchers employ it to dissect kinin pathway modulation. The peptide provides insight into structural signatures of inhibitory venom peptides.
CAT No: B09002
CAS No:30953-20-9
Synonyms/Alias:Bradykinin Potentiator C, Angiotensin I Converting Enzyme Inhibitor;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More